Skip to main content
. 2012 Oct 22;12:487. doi: 10.1186/1471-2407-12-487

Table 2.

Association between colorectal cancer and statin use among 309 cases and 294 control patients (unadjusted model) and 190 cases and 209 control patients in the adjusted model

Statin use
Unadjusted model
Adjusted model
  Cases (309) Controls (294) Basic OR* (95% CI)
Cases (194) Controls (211) Adjusted OR† (95% CI)
P-value P-value
No use of statins
284
250
1.0 (referent)
154
145
1.0 (referent)
≥1dispensed prescription at least 2 months pre-recruitment
25
44
0.52 (0.31, 0.89)
15
38
0.33 (0.15, 0.69)
0.016 **
0.004**
≥1dispensed prescription at least 7 months pre-recruitment
24
38
0.60 (0.35, 1.04)
14
32
0.39 (0.18, 0.85)
0.067
0.017**
≥2 dispensed prescriptions at least 2 months pre-recruitment
24
38
0.60 (0.35, 1.03)
14
32
0.42 (0.19, 0.92)
0.064
0.030**
≥2 dispensed prescriptions at least 7 months pre-recruitment
23
34
0.65 (0.37, 1.14)
13
28
0.49 (0.22, 1.08)
      0.135     0.077

* Adjusted for matching factors (age +/−1 year), sex and region of residence). OR = Odds ratio; CI = confidence interval.

† Adjusted for matching factors ((age +/−1 year), sex and region of residence), Family history of cancer, past medical history of cancer, past medical history of bowel disease, BMI, smoking, physical activity and regular NSAID intake.

** statistically significant at p < 0.05.